Archives

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

B 10 abstracts, including two oral presentations, reinforce Astellas’ long-term commitment to advancing oncology care TOKYO, May 18, 2026 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503,… Login to continue reading Login…

Read MoreAstellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026